Med. praxi. 2016;13(3):145-146 | DOI: 10.36290/med.2016.032

Diabetic patient treated with peritoneal dialysis

MUDr. Ivo Valkovský, Ph.D.
Interní klinika, Fakultní nemocnice Ostrava a Lékařská fakulta Ostravské univerzity

The population of elderly diabetic patients is the fastest growing group of patients entering the dialysis treatment and currently

accounts for a large part of the entire dialysis population. The prognosis of diabetic patients treated with renal replacement

therapy compared to patients without diabetes is worse, especially due to associated serious cardiovascular complications. The

case report describes a female patient with Type 1 diabetes, who was treated with peritoneal dialysis for end stage renal disease,

and later successfully transplanted.

Keywords: diabetes mellitus, peritoneal dialysis, kidney transplantation

Published: July 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Valkovský I. Diabetic patient treated with peritoneal dialysis. Med. praxi. 2016;13(3):145-146. doi: 10.36290/med.2016.032.
Download citation

References

  1. Goldfarb-Rumyantzev AS, Rout P. Characteristics of elderly patients with diabetes and end-stage renal disease. Semin Dial. 2010; 23: 185-190. Go to original source...
  2. Dusilová Sulková S. Specifické problémy u dialyzovaných diabetiků. Vnitřní lék. 2008; 54: 519-522.
  3. Hill CJ, Fogarty DG. Changing trends in end-stage renal disease due to diabetes in the United kingdom. J Ren Care. 2012; 38(Suppl 1): 12-22. Go to original source... Go to PubMed...
  4. United States Renal Data System. 2013 Annual Data Report [cit. 15. 2. 2015]. Dostupné z WWW: <http://www.usrds.org/atlas13.aspx>
  5. Statistická ročenka dialyzační léčby v České republice v roce 2013 [cit. 15. 2. 2015]. Dostupné z WWW: <http://www.nefrol.cz/odbornici/dialyzacni-statistika>
  6. Bell S, Fletcher EH, Brady I, et al. Scottish Diabetes Research Network and Scottish Renal Registry. End-stage renal disease and survival in people with diabetes: a national database linkage study. QJM. 2015; 108: 127-134. Go to original source... Go to PubMed...
  7. Locatelli F, Del Vecchio L, Cavalli A. How can prognosis for diabetic ESRD be improved? Semin Dial. 2010; 23: 214-219. Go to original source...
  8. Villar E, Chang SH, McDonald SP. Incidences, treatments, outcomes, and sex effect on survival in patients with end-stage renal disease by diabetes status in Australia and New Zealand (1991-2005). Diabetes Care. 2007; 30: 3070-3076. Go to original source...
  9. Pafčugová J. Příprava pacienta s diabetes mellitus před dialýzou a peritoneální dialýza. Postgraduální med. 2009; 4: 442-446.
  10. Smart NA, Dieberg G, Ladhani M, Titus T. Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease. Cochrane Database Syst Rev. 2014, Issue 6. Art. No.: CD007333. Go to original source...
  11. Opatrná S, Klaboch J. Specifické aspekty peritoneální dialýzy u diabetiků. Vnitřní lék. 2008; 54: 523-529.
  12. Sinnakirouchenan R, Holley JL. Peritoneal dialysis versus hemodialysis: risks, benefits, and access issues. Adv Chronic Kidney Dis. 2011; 18: 428-432. Go to original source...
  13. Locatelli F, Pozzoni P, Del Vecchio L. Renal replacement therapy in patiens with diabetes and end-stage renal disease. J Am Soc Nephrol. 2004; 15(Suppl 1): 25-29. Go to original source...
  14. Schiel R, Heinrich S, Steiner T et al. Long-term prognosis of patients after kidney transplantation: a comparison of those with or without diabetes mellitus. Nephrol Dial Transplant. 2005; 20: 611-617. Go to original source...
  15. Rychlík I, Tesař V, et al. Onemocnění ledvin u diabetes mellitus. Praha: Tigis 2005: 392-393.
  16. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease [cit. 15. 2. 2015]. Dostupné z WWW: <http://www.kdigo.org/clinical_practice_guidelines/pdf/CKD/KDIGO_2012_CKD_GL.pdf>




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.